Quality of life in a prospective, multicenter phase 2 trial of neoadjuvant full-dose gemcitabine, oxaliplatin, and radiation in patients with resectable or borderline resectable pancreatic adenocarcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 90, Issue 2, 2014, Pages 270-277

  Serrano, Pablo E ^a   Herman, Joseph M ^b   Griffith, Kent A ^c   Zalupski, Mark M ^c   Kim, Edward J ^c,d   Bekaii Saab, Tanios S ^e   Ben Josef, Edgar ^c,d   Dawson, Laura A ^f   Ringash, Jolie ^f,g   Wei, Alice C ^a,f,g  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^f PRINCESS MARGARET HOSPITAL   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMORADIOTHERAPY; DETERIORATION; FUNCTIONAL ASSESSMENT; ONCOLOGY; SURGERY; SURVEYS;

GASTROINTESTINAL SYMPTOMS; HEALTH-RELATED QUALITY OF LIVES; METHODS AND MATERIALS; NEOADJUVANT CHEMORADIATION; NEOADJUVANT THERAPY; PANCREATIC ADENOCARCINOMA; PATIENT COMPLIANCE; PHYSICAL FUNCTIONING;

DISEASES;

GEMCITABINE; OXALIPLATIN; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; PLATINUM COMPLEX;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; CANCER COMBINATION CHEMOTHERAPY; CANCER FATIGUE; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONFERENCE PAPER; DIARRHEA; DISEASE FREE SURVIVAL; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT IN CANCER PANCREATIC CANCER MODULE; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT IN CANCER QUALITY OF LIFE QUESTIONNAIRE; FEMALE; FUNCTIONAL ASSESSMENT OF CANCER THERAPY HEPATOBILIARY AND PANCREATIC SUBSCALE; GENERAL CONDITION DETERIORATION; HUMAN; LIMB WEAKNESS; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS DISEASE; PANCREATIC PAIN; PHASE 1 CLINICAL TRIAL; PROSPECTIVE STUDY; QUALITY OF LIFE; ADENOCARCINOMA; ADJUVANT THERAPY; ANALOGS AND DERIVATIVES; CHEMORADIOTHERAPY; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; HEALTH STATUS; MIDDLE AGED; PANCREAS RESECTION; PANCREATIC NEOPLASMS; PATHOLOGY; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; PROCEDURES; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CHEMORADIOTHERAPY; DEOXYCYTIDINE; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; ORGANOPLATINUM COMPOUNDS; PANCREATECTOMY; PANCREATIC NEOPLASMS; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; QUALITY OF LIFE; RADIOTHERAPY, CONFORMAL;

EID: 84908260165     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.05.053     Document Type: Conference Paper

References (30)

1. H. Oettle, S. Post, and P. Neuhaus Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: A randomized controlled trial JAMA 297 2007 267 277
2. W.F. Regine, K.A. Winter, and R.A. Abrams Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: A randomized controlled trial JAMA 299 2008 1019 1026
3. J.M. Herman, M.J. Swartz, and C.C. Hsu Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: Results of a large, prospectively collected database at the Johns Hopkins Hospital J Clin Oncol 26 2008 3503 3510
4. A. Jemal, R.C. Tiwari, and T. Murray Cancer statistics, 2004 CA Cancer J Clin 54 2004 8 29
5. M.H. Katz, R. Marsh, and J.M. Herman Borderline resectable pancreatic cancer: Need for standardization and methods for optimal clinical trial design Ann Surg Oncol 20 2013 2787 2795
6. M.H. Katz, P.W. Pisters, and D.B. Evans Borderline resectable pancreatic cancer: The importance of this emerging stage of disease J Am Coll Surg 206 2008 833 846 Discussion 846-838
7. M.S. Talamonti, W. Small Jr., and M.F. Mulcahy A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma Ann Surg Oncol 13 2006 150 158
8. M.G. Haddock, R. Swaminathan, and N.R. Foster Gemcitabine, cisplatin, and radiotherapy for patients with locally advanced pancreatic adenocarcinoma: Results of the North Central Cancer Treatment Group Phase II Study N9942 J Clin Oncol 25 2007 2567 2572
9. J. Bernhard, D. Dietrich, and W. Scheithauer Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: A randomized multicenter phase III clinical trial-SAKK 44/00-CECOG/PAN.1.3.001 J Clin Oncol 26 2008 3695 3701
10. E.J. Kim, E. Ben-Josef, and J.M. Herman A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer Cancer 119 2013 2692 2700
11. National Comprehensive Cancer Network NCCN Practice Guidelines for Pancreatic Cancer, Version 2.2012 2012 NCCN Fort Washington, PA
12. M.M. Oken, R.H. Creech, and D.C. Tormey Toxicity and response criteria of the Eastern Cooperative Oncology Group Am J Clin Oncol 5 1982 649 655
13. N.K. Aaronson, S. Ahmedzai, and B. Bergman The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 1993 365 376
14. M. Groenvold, M.C. Klee, and M.A. Sprangers Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement J Clin Epidemiol 50 1997 441 450
15. D. Fitzsimmons, C.D. Johnson, and S. George Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QOL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life Eur J Cancer 35 1999 939 941
16. N. Heffernan, D. Cella, and K. Webster Measuring health-related quality of life in patients with hepatobiliary cancers: The functional assessment of cancer therapy-hepatobiliary questionnaire J Clin Oncol 20 2002 2229 2239
17. D.F. Cella, D.S. Tulsky, and G. Gray The Functional Assessment of Cancer Therapy Scale: Development and validation of the general measure J Clin Oncol 11 1993 570 579
18. V. Velanovich Using quality-of-life instruments to assess surgical outcomes Surgery 126 1999 1 4
19. D. Osoba, and B. Zee Completion rates in health-related quality-of-life assessment: Approach of the National Cancer Institute of Canada Clinical Trials Group Stat Med 17 1998 603 612
20. J. Ringash, B. O'Sullivan, and A. Bezjak Interpreting clinically significant changes in patient-reported outcomes Cancer 110 2007 196 202
21. D. Osoba, G. Rodrigues, and J. Myles Interpreting the significance of changes in health-related quality-of-life scores J Clin Oncol 16 1998 139 144
22. M. Short, D. Goldstein, and G. Halkett Impact of gemcitabine chemotherapy and 3-dimensional conformal radiation therapy/5-fluorouracil on quality of life of patients managed for pancreatic cancer Int J Radiat Oncol Biol Phys 85 2013 157 162
23. C.P. Raut, D.B. Evans, and C.H. Crane Neoadjuvant therapy for resectable pancreatic cancer Surg Oncol Clin N Am 13 2004 639 661 ix
24. S. Heinrich, B.C. Pestalozzi, and M. Schafer Prospective phase II trial of neoadjuvant chemotherapy with gemcitabine and cisplatin for resectable adenocarcinoma of the pancreatic head J Clin Oncol 26 2008 2526 2531
25. T. Conroy, F. Desseigne, and M. Ychou FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer N Engl J Med 364 2011 1817 1825
26. B. Glimelius, K. Hoffman, and P.O. Sjoden Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer Ann Oncol 7 1996 593 600
27. A. Sadura, J. Pater, and D. Osoba Quality-of-life assessment: Patient compliance with questionnaire completion J Natl Cancer Inst 84 1992 1023 1026
28. T. Young, and J. Maher Collecting quality of life data in EORTC clinical trials-what happens in practice? Psychooncology 8 1999 260 263
29. S. Gourgou-Bourgade, C. Bascoul-Mollevi, and F. Desseigne Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: Results from the PRODIGE 4/ACCORD 11 randomized trial J Clin Oncol 31 2013 23 29
30. M.J. Morak, C.J. Pek, and E.J. Kompanje Quality of life after adjuvant intra-arterial chemotherapy and radiation therapy versus surgery alone in resectable pancreatic and periampullary cancer: A prospective randomized controlled study Cancer 116 2010 830 836